Abliva AB
Pharmaceuticals - Lund, Skane County, Sweden
Abliva AB Employees
Abliva AB Senior Management
Abliva AB Details
Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when the cell's energy provider, the mitochondria, do not function properly. The company is focused on two projects. KL1333, a powerful NAD⁺ regulator, is in clinical development and has been granted orphan drug designation in Europe and the US. NV354, an energy replacement (succinate) therapy, is in preclinical development. Abliva, based in Lund, Sweden, is listed on Nasdaq Stockholm, Sweden (ticker: ABLI).
Website:
http://www.abliva.com
Employees:
16
HQ:
+46 462756220
Location:
Lund, Skane County, Sweden
Revenue:
3.6M
Abliva AB Technologies
Email Providers
Outlook
Load Balancers
Nginx
CMS
WP Engine
Tag Management
Google Tag Manager
Other
Microsoft Office 365
Hosting
Google Cloud Hosting